Severe vulvovaginitis associated with intravaginal nystatin therapy.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 11483943.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A 64-year-old woman had severe vulvovaginitis develop while she was receiving intravaginal nystatin therapy for Candida glabrata infection. Mucocutaneous adverse effects have rarely been reported with nystatin despite long years of use. This complication should be included in the differential diagnosis of clinical failure of intravaginal nystatin therapy.
Medical subject headings
- Antifungal Agents
- Betamethasone
- Nystatin
- Vulvovaginitis